Login / Signup
Initiating Aripiprazole Lauroxil: Post Hoc Analysis of Safety and Tolerability of 1-Day and 21-Day Regimens.
Roger W Sommi
Stephen R Saklad
Peter J Weiden
Daniel Still
Meihua Wang
Sergey Yagoda
Published in:
The Journal of clinical psychiatry (2024)
Trial Registration: ClinicalTrials.gov identifiers: NCT03345979 and NCT01469039.
Keyphrases
</>
open label
phase iii
phase ii
study protocol
clinical trial
placebo controlled
double blind